Applied Therapeutics earnings were -$161.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest APLT earnings report on Jun 30, 2024 announced Q2 2024 earnings of $2.9M, down 103.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, APLT reported annual earnings of -$119.8M, with 45.2% growth. The next APLT earnings date is Nov 7, 2024.
Applied Therapeutics Earnings Reports & History FAQ
What were Applied Therapeutics's earnings last quarter?
On APLT's earnings call on Invalid Date, Applied Therapeutics (NASDAQ: APLT) reported Q2 2024 earnings per share (EPS) of $0.02, up 105.41% year over year. Total APLT earnings for the quarter were $2.90 million. In the same quarter last year, Applied Therapeutics's earnings per share (EPS) was -$0.37.
The next APLT earnings call is Invalid Date. Add APLT to your watchlist to be reminded of Applied Therapeutics's next earnings date.
Is Applied Therapeutics profitable or losing money?
As of the last Applied Therapeutics earnings report, Applied Therapeutics is currently losing money. Applied Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$161.09 million, a 119.93% increase year over year.
What was APLT's earnings growth in the past year?
As of Applied Therapeutics's earnings date in Invalid Date, Applied Therapeutics's earnings has grown year over year. APLT earnings in the past year totalled -$161.09 million.
What are Applied Therapeutics's earnings expectations?
The current EPS estimate for Applied Therapeutics's earnings report in Invalid Date is -$0.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.